Insulet Corporation (PODD) Stock Analysis

298.27

2.33%Today

Market Cap

20.99B

Volume

497.34K

52W High

329.33

52W Low

173.00

No historical price data available

No price history data available for the selected time period.

Try selecting a different time range.

Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Contact Information

Website: https://www.insulet.com
Address: 100 Nagog Park
Country: US

Investment Analysis & Insights

Key Investment Highlights

Market Position: Healthcare leader with 20.99B market capitalization
Trading Volume: 497.34K shares traded today
Price Range: 52-week range of $173.00 - $329.33
Exchange: Listed on NASDAQ Global Select

Financial Metrics

P/E Ratio:53.84

EPS:$5.54

Beta:1.35

Avg Volume:797.78K

Market Analysis for Insulet Corporation

Insulet Corporation (PODD) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 20.99B, the company represents a significant player in its market. The stock is currently trading at $298.27 with a positivedaily change of 2.33%.

The company's 3900 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 53.84, beta of 1.35, and 52-week price range from $173.00 to $329.33when evaluating investment opportunities.